Conference Coverage

Machine-learning method identifies rapid drops in patients’ activity levels to signal need for additional care
News | Artificial Intelligence
AI Model Using Daily Step Counts Predicts Unplanned Hospitalizations During Cancer Therapy

October 24, 2022 — An artificial intelligence (AI) model developed by researchers can predict the likelihood that a ...

Time October 24, 2022
arrow
Evidence from VA medical centers nationwide supports benefits of prostate cancer screening
News | Prostate Cancer
Lower Prostate Cancer Screening Rates Associated with Subsequent Increase in Advanced Cancers

October 24, 2022 — In the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings ...

Time October 24, 2022
arrow
Randomized phase III trial indicates SBRT is an option for patients ineligible for other local therapies
News | Radiation Oncology
Adding Radiation to Systemic Therapy Extends Overall Survival for Patients with Advanced Liver Cancer

October 24, 2022 — Adding radiation therapy to systemic therapy for patients with advanced liver cancer can extend ...

Time October 24, 2022
arrow
Phase II trial suggests radiation could ward off complications of bone lesions and extend overall survival for patients with advanced cancers
News | Radiation Therapy
Radiation Therapy for High-risk, Asymptomatic Bone Metastases May Prevent Pain and Prolong Life

October 23, 2022 — Treating high-risk, asymptomatic bone metastases with radiation may reduce painful complications and ...

Time October 23, 2022
arrow
Randomized, phase III clinical trial finds patients who are educated about technical aspects of care less likely to report high levels of anxiety
News | Radiation Therapy
Medical Physicist Consults with Patients can Help Reduce Anxiety and Increase Satisfaction with Radiation Care

October 23, 2022 — Meeting with a medical physicist who can explain how radiation therapy is planned and delivered ...

Time October 23, 2022
arrow
Ultra-high dose-rate radiation treatment found safe and effective for pain relief in small trial of patients with metastatic cancer
News | Proton Therapy
FLASH Radiation Therapy Shows Promise in First-in-human Trial

October 23, 2022 — FLASH radiation treatment – which delivers therapeutic doses of radiation in a fraction of a second – ...

Time October 23, 2022
arrow
Phase III study provides randomized evidence of equivalent outcomes and side effects with 5 vs. 8 weeks of radiation for high-risk disease
News | Prostate Cancer
Shortened Course of Radiation Therapy Safe and Effective for Men with High-risk Prostate Cancer

October 23, 2022 — A new randomized study confirms that men with high-risk prostate cancer can be treated with five ...

Time October 23, 2022
arrow
Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end imaging and cancer care technologies and services during the 2022 American Society for Radiation Oncology (ASTRO) annual meeting
News | Proton Therapy
Together with Siemens Healthineers, Varian Showcases Technologies and Services Spanning the Full Cancer Care Continuum at ASTRO 2022

October 21, 2022 — Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end ...

Time October 21, 2022
arrow
Clinical outcome oral presentations on SMART Pancreas and MIRAGE prostate studies Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end imaging and cancer care technologies and services during the 2022 American Society for Radiation Oncology (ASTRO) annual meeting
News | Radiation Therapy
MRIdian Clinical Studies and Initial MRIdian A3i Clinical Experience to be Highlighted at ASTRO 2022

October 21, 2022 — ViewRay, Inc. (NASDAQ: VRAY) today announced that the company's MRIdian MRI-Guided Radiation Therapy ...

Time October 21, 2022
arrow
Study highlights gender disparity in how frequently doctors and clinical trials assess the impact of treatment on sexual health
News | Clinical Case Studies
Sexual Side Effects of Cancer Treatment Often Unaddressed with Female Patients

October 21, 2022 — A new study finds that sexual side effects of cancer treatment are discussed far less frequently with ...

Time October 21, 2022
arrow
18F-SMBT-1 PET studies showed that beta-amyloid+ Alzheimer’s disease (AD) patients, but most importantly, beta-amyloid+ controls (CN) have significantly higher regional 18F-SMBT-1 binding than beta-amyloid- CN, with 18F-SMBT-1 retention highly associated with beta-amyloid burden. These findings suggest that increased 18F-SMBT-1 binding is detectable at the preclinical stages of beta-amyloid accumulation.
News | PET Imaging
Novel PET Imaging Agent Detects Earliest Signs of Alzheimer's Disease

October 20, 2022 — A new highly selective PET imaging agent can detect the presence of overexpressed monoamine oxidase-B ...

Time October 20, 2022
arrow
FDA 510(k) clearance for AI-enabled Philips MR for Calculating Attenuation (MRCAT) Head and Neck radiotherapy application expands range of MR-only workflows
News | Magnetic Resonance Imaging (MRI)
Philips Advances MR Radiotherapy Imaging and Simulation for Head and Neck Cancers

October 20, 2022 — Royal Philips, a global leader in health technology, announced two new advances in MR-only workflows ...

Time October 20, 2022
arrow
Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced the signing of a data-sharing agreement with Siemens Healthineers and the University Hospital of the Technical University of Munich (TUM) for anonymized 18F-rhPSMA-7.3 clinical data and images.
News | PET Imaging
Blue Earth Diagnostics Announces Data-sharing Agreement with Siemens Healthineers and the University Hospital of Technical University of Munich (TUM) for 18F-rhPSMA-7.3

October 19, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 19, 2022
arrow
Left: Recombined image of the CEM exam showing iodine uptake. Right: Standard digital mammogram.
News | Breast Imaging
American College of Radiology (ACR) Launches Contrast-Enhanced Mammography Imaging Screening Trial (CMIST) in Collaboration With GE Healthcare and the Breast Cancer Research Foundation

October 19, 2022 — The American College of Radiology (ACR) is set to launch the Contrast-Enhanced Mammography Imaging ...

Time October 19, 2022
arrow
Based on Spectrum Dynamics digital SPECT/CT platform, VERITON-CT 400 Series provides the benefits of increased sensitivity and throughput to clinical applications based on high energy isotopes used in Nuclear Medicine
News | SPECT-CT
World's First Digital SPECT/CT Capable of High Energy Imaging Enables Full Range of Clinical Capabilities to Nuclear Medicine Centers

October 18, 2022 — Spectrum Dynamics announced its newest development in digital nuclear medicine imaging: the ...

Time October 18, 2022
arrow
A new report from a joint task force of the American College of Radiology (ACR) and the Society of Interventional Radiology (SIR) recommends improved access to interventional radiologists (IRs) in small and rural areas.
News | Interventional Radiology
New Report Highlights Need for Recruitment, Retention of Interventional Radiologists to Small and Rural Practices

October 14, 2022 — A new report from a joint task force of the American College of Radiology (ACR) and the Society of ...

Time October 14, 2022
arrow
54-year-old with pathologically confirmed inflammatory adenoma in left lobe that underwent evaluation by gadoxetate disodium-enhanced MRI. Axial T1-weighted fat-saturated precontrast image shows isointensity to liver of adenoma (arrow). Axial arterial-phase postcontrast image shows hyperintensity to liver (arrow). Axial portal-venous phase postcontrast image shows hyperintensity to liver (arrow). Axial hepatobiliary-phase postcontrast image shows hyperintensity to liver (arrow). Hepatobiliary-phase liver-to
News | Magnetic Resonance Imaging (MRI)
Gadoxetate Disodium–Enhanced MRI Algorithm Identifies Hepatocellular Adenomas

October 12, 2022 — According to an article in ARRS’ American Journal of Roentgenology (AJR), findings on gadoxetate ...

Time October 12, 2022
arrow
Mirion Technologies, Inc., a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the appointment of Michael Rossi as the President of Mirion Medical. Michael will report directly to Mirion’s CEO, Tom Logan, who had been acting as President of the business segment.
News | Quality Assurance (QA)
Mirion Technologies Appoints Michael Rossi as President of Mirion Medical

October 7, 2022 — Mirion Technologies, Inc., a global provider of radiation detection, measurement, analysis and ...

Time October 07, 2022
arrow
Program details on keynote addresses, distinguished awards and late-breaking abstracts are being provided by program planners of the American Society for Radiation Oncology (ASTRO) Annual Meeting, set for October 23-26, in San Antonio, TX.
News | ASTRO
Looking Ahead to ASTRO: Keynotes, Awards and Scientific Session Updates

October 6, 2022 ‑— Ahead of the 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO), set for ...

Time October 06, 2022
arrow
The center will be equipped with a Cyclone KIUBE offering the highest production capacity with a PET cyclotron.
News | Radiopharmaceuticals and Tracers
ElsMed, Novatec and IBA Sign Contract to Install Radiopharmaceutical Production Center in Georgia

October 6, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the ...

Time October 06, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now